Clinical Trial

Supplementation With Sirtuin Activators in Women With Increased Body Weight

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the six-month supplementation with sirtuin activators can affect metabolism in 40-to-65-year old women with increased body weight. The main questions it aims to answer are: Does sirtuin activators affect lipid and carbohydrate metabolism? Does sirtuin activators affect oxydative stress, immune functions and cell ageing? Researchers will compare sirtuin activators to a placebo (a look-alike substance that contains no drug) to see if drug sirtuin activators works to improve metabolic status. Participants will: Take sirtuin activators or a placebo every day for 6 months. Visit the university once every 3 months for checkups and tests.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-17; most recent amendment 2026-05-19.
Trial Details
NCT Number NCT07245979
Lead Sponsor Poznan University of Life Sciences
Collaborators: Poznan University of Medical Sciences, NutroPharma
Conditions Obesity & Overweight
Enrollment 120 participants
Start Date 2025-10-08
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-22